Tag: Guide

Essential Patent and IP Protection Resources for Foreign Biotech Companies in China

CG360-BIOTECH-RESO-051 — Essential Patent and IP Protection Resources for Foreign Biotech Companies in China *{margin:0;padding:0;box-sizing:border-bo

Essential Clinical Trial (CDE) Compliance Resources for Foreign Sponsors in China

Essential Clinical Trial (CDE) Compliance Resources for Foreign Sponsors in China | CG360-BIOTECH-RESO-050 *{margin:0;padding:0;box-sizing:border-box}

Essential Biotech Park and Incubator Resources for Foreign Life Sciences Firms in China

CG360-BIOTECH-RESO-049 — Essential Biotech Park and Incubator Resources for Foreign Life Sciences Firms in China *, *::before, *::after { box-sizing:

Essential NMPA Drug Registration Resources for Foreign Biotech Companies in China

Essential NMPA Drug Registration Resources for Foreign Biotech Companies in China | CG360-BIOTECH-RESO-048 *{margin:0;padding:0;box-sizing:border-box}

How to Navigate China’s Patent Linkage System for Biologics: 2026 Guide

How to Navigate China's Patent Linkage System for Biologics: 2026 Guide China's Patent Linkage System (药品专利链接制度, Drug Patent Linkage System, yàopǐn zh

How AstraZeneca Expanded Biologics Manufacturing in China Through Wuxi Biotech Park Incentives: A Case Study in Strategic Localization

How AstraZeneca Expanded Biologics Manufacturing in China Through Wuxi Biotech Park Incentives: A Case Study in Strategic Localization In 2022, AstraZ